These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28565965)

  • 1. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur J Cardiovasc Nurs; 2017 Jun; 16(5):369-380. PubMed ID: 28565965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur J Prev Cardiol; 2016 Dec; 23(18):1994-2006. PubMed ID: 27600690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):299-310. PubMed ID: 28608759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
    Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
    Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical compliance to evidence-based clinical guidelines on secondary prevention of coronary heart disease in a hospital from Lima, Peru: a retrospective study.
    Castañeda-Amado Z; Calixto-Aguilar L; Loza Munarriz C; Medina Palomino FA
    Medwave; 2017 Jun; 17(5):e6989. PubMed ID: 28665919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving national service framework standards for cardiac rehabilitation and secondary prevention.
    Dalal HM; Evans PH
    BMJ; 2003 Mar; 326(7387):481-4. PubMed ID: 12609946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative.
    Ades PA; Keteyian SJ; Wright JS; Hamm LF; Lui K; Newlin K; Shepard DS; Thomas RJ
    Mayo Clin Proc; 2017 Feb; 92(2):234-242. PubMed ID: 27855953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
    Wang WT; Hellkamp A; Doll JA; Thomas L; Navar AM; Fonarow GC; Julien HM; Peterson ED; Wang TY
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29371200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
    BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning secondary prevention: Room for improvement.
    Cortés-Beringola A; Fitzsimons D; Pelliccia A; Moreno G; Martín-Asenjo R; Bueno H
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):22-28. PubMed ID: 28618903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
    Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
    Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease.
    Schmid O; Chalmers L; Bereznicki L
    J Clin Pharm Ther; 2015 Aug; 40(4):398-403. PubMed ID: 25924028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavourable risk factor control after coronary events in routine clinical practice.
    Sverre E; Peersen K; Husebye E; Gjertsen E; Gullestad L; Moum T; Otterstad JE; Dammen T; Munkhaugen J
    BMC Cardiovasc Disord; 2017 Jan; 17(1):40. PubMed ID: 28109259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland.
    Gasior M; Gierlotka M; Pyka Ł; Zdrojewski T; Wojtyniak B; Chlebus K; Rozentryt P; Niedziela J; Jankowski P; Nessler J; Opolski G; Hoffman P; Jankowska E; Polonski L; Ponikowski P
    Eur J Prev Cardiol; 2018 Jun; 25(9):960-969. PubMed ID: 29692221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who needs secondary prevention?
    Frederix I; Dendale P; Schmid JP
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):8-13. PubMed ID: 28618916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.